A National Institutes of Health-led review of more than 24,000 stored blood samples suggests that the coronavirus that causes COVID-19 was present in the U.S. as far back as December 2019. The samples were collected between January and mid-March 2020 and contributed by participants in NIH’s All of Us research program in all 50 states.

Two separate serology tests revealed SARS-CoV-2 antibodies in a small number of patients from samples collected as early as Jan. 7 from patients in Illinois, Massachusetts, Mississippi, Pennsylvania and Wisconsin, which suggests that the virus was present in the U.S. in late December. The study authors note that it is unknown whether participants who provided positive samples became infected through their travels or while in their own communities.

Related News Articles

Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…